NovaQuest Capital Management LLC

Search
⚲

NovaQuest Capital Management LLC ✚
CRD #	160359
SEC #	801-73992
CIK #	0001729264
AUM	1,483.0 M (2026-03-31)
Employees	18 (100% Investors, 0% Brokers)
Fees
Minimum
Phone	919-459-8620
Address
Source	[IAPD] [EDGAR] [Website] [LinkedIn]

Total AUM ($B) Copy

Type	Form D Funds	Date	Sold	AUM
PE	NovaQuest Pharma Opportunities Fund VI Aggregator LP	[2025-03-31]	90.0 M	10.8 M
	Offered $800,000,000 · Filed 2024-06-12 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $30,000,000 · Remaining $710,000,000 · Duration More than one year · Finder's Fee $540,675 · Revenue Not Applicable
PE	NovaQuest Pharma Opportunities Fund VI LP	[2024-03-29]	90.0 M	73.9 M
	Offered $800,000,000 · Filed 2024-06-12 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $30,000,000 · Remaining $710,000,000 · Duration More than one year · Finder's Fee $540,675 · Revenue Not Applicable
PE	NQ Project Lockport LP	2024-03-29		13.9 M
PE	NovaQuest Co-Investment Fund XVII LP	2023-03-31		40.2 M
PE	NQ Ah Project Arlington II LP	2023-03-31		21.3 M
PE	NQ Project Bridgeton LP	2023-03-31		100.1 M
PE	NQ Project Glasgow Ltd	2023-03-31		4.3 M
PE	NQ Project Pharaoh LP	2023-03-31		138.0 M
PE	NQ Project Phoebus LP	2023-03-31		58.5 M
PE	NQ Project Sampson LP	2023-03-31		46.4 M
PE	NovaQuest Animal Health Opportunities Fund Aggregator LP	2022-03-31		131.8 M
PE	NovaQuest Animal Health Opportunities Fund Delaware LP	[2022-03-31]	80.6 M	140.8 M
	Offered $250,000,000 · Filed 2023-06-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,555,556 · Remaining $169,444,444 · Duration More than one year · Finder's Fee $47,000 · Revenue Not Applicable
PE	NovaQuest Animal Health Opportunities Fund LP	[2022-03-31]	80.6 M	10.3 M
	Offered $250,000,000 · Filed 2023-06-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,555,556 · Remaining $169,444,444 · Duration More than one year · Finder's Fee $47,000 · Revenue Not Applicable
PE	NovaQuest Co-Investment Fund XVIII LP	2022-03-31		49.8 M
PE	NovaQuest Co-Investment Fund XVI LP	2022-03-31		109.0 M
PE	NovaQuest Co-Investment Fund XV LP	2022-03-31		9.3 M
PE	NQ Cove Aggregator LP	2022-03-31		40.6 M
PE	NovaQuest Co-Investment Fund I Parent LP	2021-03-30		0.7 M
PE	NovaQuest Co-Investment Fund XIII LP	2021-03-30		23.9 M
PE	NovaQuest Co-Investment Fund XIV LP	2021-03-30		30.8 M
PE	NovaQuest Co-Investment Fund IX LP	2020-03-30		70.0 M
PE	NovaQuest Co-Investment Fund Xi LP	2020-03-30		35.8 M
PE	NovaQuest Co-Investment Fund X LP	2020-03-30		5.9 M
PE	NQP SPV II LP	2020-03-30		104.9 M
PE	NovaQuest Co-Investment Fund VIII LP	2019-03-31		121.1 M
PE	NovaQuest Co-Investment Fund VII LP	[2019-03-31]	35.0 M	57.7 M
	Offered $35,000,000 · Filed 2018-06-13 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Co-Investment - RISP LP	2019-03-31		20.7 M
PE	NovaQuest Co-Investment - Tak LP	2019-03-31
PE	NovaQuest Fund III AIV I LP	2019-03-31		0.4 M
PE	NovaQuest Pharma Opportunities Fund III Aggregator LP	2019-03-31		31.7 M
PE	NovaQuest Pharma Opportunities Fund IV Aggregator LP	2019-03-31		72.9 M
PE	NovaQuest Pharma Opportunities Fund IV Co-Invest-A LP	2019-03-31		2.2 M
PE	NQP AIV I LP	2019-03-31		50.9 M
PE	NQP SPV I LP	2019-03-31		71.6 M
PE	NovaQuest Co-Investment Fund VI LP	[2018-03-29]	25.0 M	32.1 M
	Offered $25,000,000 · Filed 2017-07-13 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Pharma Opportunities Fund V Delaware LP	[2018-03-29]	892.8 M	376.7 M
	Offered $1,500,000,000 · Filed 2019-06-21 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $607,250,000 · Duration More than one year · Revenue Decline to Disclose
PE	NovaQuest Pharma Opportunities Fund V LP	[2018-03-29]	892.8 M	603.4 M
	Offered $1,500,000,000 · Filed 2019-06-21 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $607,250,000 · Duration More than one year · Revenue Decline to Disclose
PE	NovaQuest Co-Investment Fund V LP	2017-03-30		0.1 M
PE	NovaQuest Pharma Opportunities Fund IV Co-Invest-A LP	2017-03-30		8.3 M
PE	NovaQuest Co-Investment Fund III LP	2016-03-30		32.5 M
PE	NovaQuest Co-Investment Fund II LP	2016-03-30		1.4 M
PE	NovaQuest Co-Investment Fund IV LP	[2016-03-30]	150.0 M
	Offered $150,000,000 · Filed 2016-01-28 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Pharma Opportunities Fund IV Co-Invest LP	[2016-03-30]	75.0 M	53.2 M
	Offered $75,000,000 · Filed 2015-12-28 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $75,000,000 · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Pharma Opportunities Fund IV LP	[2016-03-30]		125.7 M
	Offered $850,000,000 · Filed 2015-06-11 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $850,000,000 · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Pharma Opportunities Fund IV Parallel LP	[2016-03-30]	75.0 M	13.8 M
	Offered $75,000,000 · Filed 2015-12-28 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $75,000,000 · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Co-Investment Fund I LP	[2014-03-27]	80.0 M	194.8 M
	Filed 2013-05-03 (D) · Exemption 3(c), 3(c)(1), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE	NovaQuest Pharma Opportunities Fund III LP	[2012-02-14]	426.1 M	48.1 M
	Offered $500,000,000 · Filed 2012-11-14 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining $73,900,500 · Duration More than one year · Revenue Decline to Disclose

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	14	1.5
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	14	1.5
By Discretionary
Discretionary	14	1.5
Non-Discretionary	0	0.0
Total	14	1.5
By Non-United States Persons
Non-United States Persons		0.4
United States Persons		1.1
Total	14	1.5

Form D Directors	Role	# Filings	# Firms
James O'Brien	Director	57	10
Fred Cohen	Director	45	5
Chris Gordon	Director	23	3
Ronald Wooten	Director	23	3
Ernest Brown	Director	22	3
John Bradley	Director	21	3
Carl Hellman	Director	10	3
Ryan Applegate	Director	9	3
John Bradley Jr	Director	6	3
NQ Pof IV GP Ltd	Executive Officer	8	2
View All

EDGAR Form	CIK	2011 - 2026
13F-HR	[0001729264]

Firm Profile (Form ADV)
Discretionary AUM	$0.5B
Serves	Institutional
Fund Types	Private Equity
LEI	5493000LUNI6LGVHU343

Comparable Firms	State	AUM
Ariel Alternatives LLC ✚	IL	1,511.0 M
Excelsior Renewable Energy Management Company LP ✚	MN	1,505.4 M
PRV Management LP ✚	CO	1,502.7 M
Mountaingate Management Co LLC ✚	CO	1,492.9 M
Brookside Equity Partners LLC ✚	CT	1,490.2 M
Springcoast Capital Partners LP ✚	NY	1,489.5 M
Yucaipa Master Manager LLC ✚	CA	1,488.1 M
H Barton Asset Management LLC ✚	CA	1,481.1 M
Czech Asset Management LP ✚	CT	1,479.9 M
Raven Credit Capital Management LLC ✚	NY	1,460.2 M

NovaQuest Capital Management LLC

Assets, Funds, Holdings